HCW Biologics Inc. (HCWB) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
HCW Biologics Inc. (HCWB) Bundle
Simplify HCW Biologics Inc. (HCWB) valuation with this customizable DCF Calculator! Featuring real HCW Biologics Inc. (HCWB) financials and adjustable forecast inputs, you can test scenarios and uncover HCW Biologics Inc. (HCWB) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | 4.1 | .0 | 6.7 | 2.8 | 1.7 | 1.0 | .6 | .4 | .2 |
| Revenue Growth, % | 0 | 0 | -100 | 0 | -57.72 | -39.43 | -39.43 | -39.43 | -39.43 | -39.43 |
| EBITDA | -6.9 | -5.3 | -12.8 | -14.2 | -23.6 | -.3 | -.2 | -.1 | -.1 | .0 |
| EBITDA, % | 100 | -128.1 | 100 | -211.01 | -829.62 | -20 | -20 | -20 | -20 | -20 |
| Depreciation | .4 | .6 | .5 | .6 | 1.1 | .9 | .5 | .3 | .2 | .1 |
| Depreciation, % | 100 | 13.97 | 100 | 8.77 | 39.95 | 52.54 | 52.54 | 52.54 | 52.54 | 52.54 |
| EBIT | -7.4 | -5.8 | -13.4 | -14.8 | -24.7 | -.3 | -.2 | -.1 | -.1 | .0 |
| EBIT, % | 100 | -142.07 | 100 | -219.78 | -869.56 | -20 | -20 | -20 | -20 | -20 |
| Total Cash | 7.4 | 8.5 | 36.7 | 32.1 | 3.6 | 1.7 | 1.0 | .6 | .4 | .2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | 2.5 | .1 | .4 | 1.5 | 1.1 | .7 | .4 | .2 | .1 |
| Account Receivables, % | 100 | 60.98 | 100 | 6.21 | 54.04 | 64.25 | 64.25 | 64.25 | 64.25 | 64.25 |
| Inventories | .0 | .5 | 2.2 | 1.4 | .0 | .8 | .5 | .3 | .2 | .1 |
| Inventories, % | 100 | 13.13 | 100 | 20.75 | 0 | 46.78 | 46.78 | 46.78 | 46.78 | 46.78 |
| Accounts Payable | .4 | .2 | .2 | 1.2 | 6.2 | 1.1 | .7 | .4 | .2 | .1 |
| Accounts Payable, % | 100 | 3.79 | 100 | 18.24 | 217.02 | 64.41 | 64.41 | 64.41 | 64.41 | 64.41 |
| Capital Expenditure | -1.5 | -.2 | .0 | -10.3 | -6.2 | -.7 | -.4 | -.3 | -.2 | -.1 |
| Capital Expenditure, % | 100 | -4.55 | 100 | -152.86 | -218.26 | -40.91 | -40.91 | -40.91 | -40.91 | -40.91 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -7.3 | -5.8 | -12.8 | -14.6 | -24.7 | -.3 | -.2 | -.1 | -.1 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -7.9 | -8.7 | -11.6 | -22.8 | -24.6 | -5.6 | .2 | .1 | .1 | .1 |
| WACC, % | 7.24 | 7.25 | 7.2 | 7.24 | 7.25 | 7.23 | 7.23 | 7.23 | 7.23 | 7.23 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -4.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 1 | |||||||||
| Present Terminal Value | 1 | |||||||||
| Enterprise Value | -4 | |||||||||
| Net Debt | 3 | |||||||||
| Equity Value | -7 | |||||||||
| Diluted Shares Outstanding, MM | 36 | |||||||||
| Equity Value Per Share | -0.19 |
What You Will Get
- Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: HCW Biologics Inc. (HCWB) financial data pre-loaded to enhance your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A refined Excel model tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and optimizing time efficiency.
Key Features
- Comprehensive HCWB Data: Pre-loaded with HCW Biologics Inc.’s historical performance metrics and future forecasts.
- Customizable Assumptions: Modify growth rates, profit margins, discount rates, tax considerations, and capital investments.
- Interactive Valuation Framework: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
- Intuitive Interface: Designed to be straightforward and accessible for both seasoned professionals and newcomers.
How It Works
- Download the Template: Gain immediate access to the Excel-based HCW Biologics Inc. (HCWB) DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates HCW Biologics Inc.'s (HCWB) intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation fluctuations.
- Analyze and Decide: Utilize the findings to inform your investment or financial evaluations.
Why Choose This Calculator for HCW Biologics Inc. (HCWB)?
- Designed for Industry Experts: A sophisticated tool tailored for biopharmaceutical analysts, investors, and researchers.
- Comprehensive Data: HCW Biologics’ historical and projected financials are preloaded for precise analysis.
- Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions to assess potential outcomes.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and other critical financial metrics.
- User-Friendly Interface: Step-by-step guidance makes the process straightforward and accessible.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling HCW Biologics Inc. (HCWB) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for HCW Biologics Inc. (HCWB).
- Consultants: Deliver professional valuation insights on HCW Biologics Inc. (HCWB) to clients quickly and accurately.
- Business Owners: Understand how biopharmaceutical companies like HCW Biologics Inc. (HCWB) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to HCW Biologics Inc. (HCWB).
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled HCW Biologics Inc. (HCWB) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for HCW Biologics Inc. (HCWB).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.